Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: A mechanism for the generation of glucocorticoid resistance
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Inflammatory responses in many cell types are coordinately regulated by the opposing actions of NF-κB and the glucocorticoid receptor (GR). The human glucocorticoid receptor (hGR) gene encodes two protein isoforms: a cytoplasmic alpha form (GRα), which binds hormone, translocates to the nucleus, and regulates gene transcription, and a nuclear localized beta isoform (GRβ), which does not bind known ligands and attenuates GRα action. We report here the identification of a tumor necrosis factor (TNF)-responsive NF-κB DNA binding site 5′ to the hGR promoter that leads to a 1.5-fold increase in GRα mRNA and a 2.0-fold increase in GRβ mRNA in HeLaS3 cells, which endogenously express both GR isoforms. However, TNF-α treatment disproportionately increased the steady-state levels of the GRβ protein isoform over GRα, making GRβ the predominant endogenous receptor isoform. Similar results were observed following treatment of human CEMC7 lymphoid cells with TNF-α or IL-1. The increase in GRβ protein expression correlated with the development of glucocorticoid resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“treatment of HeLaS3 and CEMC7 cells with either TNF-α or IL-1 was shown to increase hGR β expression two-fold, while only increasing hGR-α 1.5-fold.75”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [75]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane
Fairbanks, G., Steck, T. L., & Wallach, D. F. H. (1971) · Biochemistry · doi:10.1021/bi00789a030 · Cited by 8,526
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819
Self-citationInhaled Glucocorticoids for Asthma
Barnes, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321307 · Cited by 629
The Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Sar, M., & Cidlowski, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9550 · Cited by 562
Self-citationCaldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A., & Van der Saag, P. T. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.4.7659084 · Cited by 489
The Dominant Negative Activity of the Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Jewell, C. M., Yudt, M. R., Bofetiado, D. M., & Cidlowski, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27857 · Cited by 453
Self-citationAssociation of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β
Leung, D. Y. M., Hamid, Q., Vottero, A., Szefler, S. J., Surs, W., Minshall, E., Chrousos, G. P., & Klemm, D. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1567 · Cited by 415
McKay, L. I., & Cidlowski, J. A. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0044 · Cited by 405
Self-citationZabel, U., Schreck, R., & Baeuerle, P. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52428-5 · Cited by 344
Increased Glucocorticoid Receptor β in Airway Cells of Glucocorticoid-insensitive Asthma
HAMID, Q. A., WENZEL, S. E., HAUK, P. J., TSICOPOULOS, A., WALLAERT, B., LAFITTE, J.-J., CHROUSOS, G. P., SZEFLER, S. J., & LEUNG, D. Y. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9804131 · Cited by 292
Inflammatory mechanisms in Alzheimer's disease
Eikelenboom, P., Zhan, S.-S., van Gool, W. A., & Allsop, D. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90057-4 · Cited by 291
Pro-inflammatory signaling: Last pieces in the NF-κB puzzle?
Baeuerle, P. A. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70010-7 · Cited by 277
Sousa, A. R., Lane, S. J., Cidlowski, J. A., Staynov, D. Z., & Lee, T. H. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106486 · Cited by 274
Self-citationTHE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
Breitner, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.401 · Cited by 263
Webster, J. C., Jewell, C. M., Bodwell, J. E., Munck, A., Sar, M., & Cidlowski, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9287 · Cited by 261
Self-citationHonda, M., Orii, F., Ayabe, T., Imai, S., Ashida, T., Obara, T., & Kohgo, Y. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70172-7 · Cited by 252
Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens
Hauk, P. J., Hamid, Q. A., Chrousos, G. P., & Leung, D. Y. M. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.105807 · Cited by 202
de Castro, M., Elliot, S. J., Kino, T., Bamberger, C. M., Karl, M., Webster, E., & Chrousos, G. P. (1996) · Molecular Medicine · doi:10.1007/bf03401643 · Cited by 195
Expression and Subcellular Distribution of the β-Isoform of the Human Glucocorticoid Receptor*
Oakley, R. H., Webster, J. C., Sar, M., Parker, C. R., & Cidlowski, J. A. (1997) · Endocrinology · doi:10.1210/endo.138.11.5501 · Cited by 193
Self-citationde Castro, M., Elliot, S. J., Kino, T., Bamberger, C. M., Karl, M., Webster, E., & Chrousos, G. P. (1996) · PubMed Central · Cited by 181
Glucocorticoid Resistance in Asthma
Barnes, P. J., Greening, A. P., & Crompton, G. K. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/152.6_pt_2.s125 · Cited by 157
Macanovic, M., Sinicropi, D., Shak, S., Baughman, S., Thiru, S., & Lachmann, P. J. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-839.x · Cited by 152
Shahidi, H., Vottero, A., Stratakis, C. A., Taymans, S. E., Karl, M., Longui, C. A., Chrousos, G. P., Daughaday, W. H., Gregory, S. A., & PLATE, J. M. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9980 · Cited by 126
Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation.
Burnstein, K. L., Jewell, C. M., & Cidlowski, J. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39112-4 · Cited by 125
Self-citationHarmon, J. M., & Thompson, E. B. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.6.512 · Cited by 104
Zong, J., Ashraf, J., & Thompson, E. B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5580 · Cited by 103
Expression and Subcellular Distribution of the -Isoform of the Human Glucocorticoid Receptor
Oakley, R. H. (1997) · Endocrinology · doi:10.1210/en.138.11.5028 · Cited by 103
Self-citationBurnstein, K. L. (1994) · Molecular Endocrinology · doi:10.1210/me.8.12.1764 · Cited by 102
Self-citationAllgood, V. E., Oakley, R. H., & Cidlowski, J. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36867-x · Cited by 93
Self-citationAsai, K., Funaki, C., Hayashi, T., Yamada, K., Naito, M., Kuzuya, M., Yoshida, F., Yoshimine, N., & Kuzuya, F. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.892 · Cited by 89
Silva, C. M., Tully, D. Β., Petch, L. A., Jewell, C. M., & Cidlowski, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.1744 · Cited by 79
Self-citationJewell, C. M., Webster, J. C., Burnstein, K. L., Sar, M., Bodwell, J. E., & Cidlowski, J. A. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00174-x · Cited by 65
Self-citationOakley, R. H. (1999) · Steroids · doi:10.1016/s0039-128x(99)00059-8 · Cited by 63
Self-citationVoisard, R., Seitzer, U., Baur, R., Dartsch, P. C., Osterhues, H. H., Höher, M., & Hombach, V. (1994) · International Journal of Cardiology · doi:10.1016/0167-5273(94)90206-2 · Cited by 56
Vitamin B6 influences glucocorticoid receptor-dependent gene expression.
Allgood, V. E., Powell-Oliver, F. E., & Cidlowski, J. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38364-4 · Cited by 54
Self-citationVig, E., Barrett, T. J., & Vedeckis, W. V. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.10.7854351 · Cited by 48
Matsuda, Y., Yamanaka, H., Higami, K., & Kashiwazaki, S. (1998) · PubMed · Cited by 43
Hagihara, H., Nomoto, A., Mutoh, S., Yamaguchi, I., & Ono, T. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90192-6 · Cited by 41
Molecular Aspects of Inflammatory and Immune Responses in Alzheimer's Disease
Kalaria, R. N., Harshbarger-Kelly, M., Cohen, D., & Premkumar, D. R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00114-5 · Cited by 40
Pariante, C. M., Pearce, B. D., Pisell, T. L., Sanchez, C. I., Po, C., Su, C., & Miller, A. H. (1999) · Endocrinology · doi:10.1210/en.140.9.4359 · Cited by 40
Molecular Mechanisms of Clucocorticoid Resistance/Hypersensitivity: Potential Clinical Implications
Chrousos, G. P., de Castro, M., Leung, D. Y. M., Webster, E., Kino, T., Bamberger, C. M., Elliot, S. J., Stratakis, C. A., & Karl, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s39 · Cited by 26
Increased Steroid Responsiveness during Sodium Butyrate-induced “Differentiation” of HeLa S3Cells*
Littlefield, B. A., & Cidlowski, J. A. (1984) · Endocrinology · doi:10.1210/endo-114-2-566 · Cited by 18
Self-citationNew Insights into the Pathogenesis and Management of Steroid-Resistant Asthma
Spahn, J. D., Leung, D. Y. M., & Szefler, S. J. (1997) · Journal of Asthma · doi:10.3109/02770909709068188 · Cited by 18
Heytman, M., Ahern, M. J., Smith, & Roberts-Thomson, P. J. (1994) · PubMed · Cited by 18
Tully, D. Β., & Cidlowski, J. A. (1989) · Biochemistry · doi:10.1021/bi00431a003 · Cited by 15
Self-citationCorticosteroids in the treatment of rheumatologic diseases
Weisman, M. H. (1996) · Current Opinion in Rheumatology · doi:10.1097/00002281-199605000-00004 · Cited by 13
Decreased Sensitivity to Dexamethasone in Lymphocytes from Patients with Alzheimer's Disease
Nijhuis, E. W. P., Hinloopen, B., van Duijn, C. M., Albert Hofman, D., Rozing, J., & Nagelkerken, L. M. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1168 · Cited by 9
Update on pharmacotherapy of systemic lupus erythematosus
Redford, T. W., & Small, R. E. (1995) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/52.23.2686 · Cited by 6
Corticosteroids in the treatment of rheumatologic diseases
Weisman, M. H. (1995) · Current Opinion in Rheumatology · doi:10.1097/00002281-199505000-00005 · Cited by 6
Research works printed but not linked: 8
- E Caldenhoven, J Liden, S Wissink, A Van de Stolpe, J Raaijimakers, L Koenderman, S Okret, J A Gustafsson, P T Van der Saag Mol Endocrinol 9, 401–412 (1995).
- K L Burnstein, C M Jewell, M Sar, J A Cidlowski Mol Endocrinol 8, 1764–1773 (1994).
- J Zong, J Ashraf, E B Thompson Mol Cell Biol 10, 5580–5585 (1990).
- J C Webster, C M Jewell, M Sar, J A Cidlowski Endocrine J 2, 967–969 (1994).
- C Gorman DNA Cloning: A Practical Approach, ed D M Glover (IRL, Oxford) III, 143–190 (1985).
- E Vig, T J Barrett, W V Vadeckis Mol Endocrinol 8, 1336–1346 (1994).
- Y Matsuda, H Yamanaka, K Higami, S Kashiwazaki J Rheumatol 25, 427–432 (1998).
- M Heytman, M J Ahern, M D Smith, PJ Roberts-Thomson J Rheumatol 21, 435–441 (1994).
Cited by
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Self-citationUchino, B. N. (2006) · Journal of Behavioral Medicine · doi:10.1007/s10865-006-9056-5 · Cited by 2,507
“For instance, proinflammatory cytokines such as tumor necrosis factor-α can modulate glucocorticoid receptors on cytokine producing cells (Webster et al., 2001).”
BackgroundImmune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Metadata
- Authors
- Webster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Cidlowski, John A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-05-29
- Volume
- 98
- Issue
- 12
- Pages
- 6865-6870
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC34444
- OpenAlex
- W2099803817
- Cited by
- 482
- References
- 58
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 10 · 2023: 9 · 2022: 14 · 2021: 20 · 2020: 18 · 2019: 17 · 2018: 19 · 2017: 17 · 2016: 21 · 2015: 22 · 2014: 21 · 2013: 25 · 2012: 22
- FWCI
- 13.83
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- glucocorticoid receptor, glucocorticoid resistance, inflammatory cytokines, NF-κB, TNF-α, interleukin-1, glucocorticoid receptor alpha, glucocorticoid receptor beta, gene expression regulation, lymphoid cells, HeLa S3 cells
- MeSH terms
- Animals, Drug Resistance, Gene Expression Regulation, Glucocorticoids, HeLa Cells, Humans, Interleukin-1, Receptors, Glucocorticoid, RNA, Messenger, Tumor Necrosis Factor-alpha, Cytokines, NF-kappa B, COS Cells, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.